Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/13385
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorDasko, Mateusz-
dc.creatorRamos González, Ana-
dc.creatorCoderch Boué, Claire-
dc.creatorPascual-Teresa Fernández, Beatriz de-
dc.date2022-
dc.date.accessioned2022-02-15T05:00:18Z-
dc.date.available2022-02-15T05:00:18Z-
dc.date.issued2022-02-15-
dc.identifier000000726410-
dc.identifier.urihttp://hdl.handle.net/10637/13385-
dc.descriptionMolecules, e-ISSN 1420-3049, 2022, 27, 715-
dc.description.abstractHistone deacetylases (HDACs) are a large family of epigenetic metalloenzymes that are involved in gene transcription and regulation, cell proliferation, differentiation, migration, and death, as well as angiogenesis. Particularly, disorders of the HDACs expression are linked to the development of many types of cancer and neurodegenerative diseases, making them interesting molecular targets for the design of new efficient drugs and imaging agents that facilitate an early diagnosis of these diseases. Thus, their selective inhibition or degradation are the basis for new therapies. This is supported by the fact that many HDAC inhibitors (HDACis) are currently under clinical research for cancer therapy, and the Food and Drug Administration (FDA) has already approved some of them. In this review, we will focus on the recent advances and latest discoveries of innovative strategies in the development and applications of compounds that demonstrate inhibitory or degradation activity against HDACs, such as PROteolysis-TArgeting Chimeras (PROTACs), tumor-targeted HDACis (e.g., folate conjugates and nanoparticles), and imaging probes (positron emission tomography (PET) and fluorescent ligands).en_EN
dc.formatapplication/pdf-
dc.language.isoen-
dc.relationThis research was funded by MINECO/FEDER, UE, grant number RTI2018-093539-B-I00. M.D. was supported by a fellowship in the Bekker programme (PPN/BEK/2020/1/00096/U/00001), funded by the Polish National Agency for Academic Exchange.en_EN
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectHistone deacetylases (HDACs)en_EN
dc.subjectPROTACsen_EN
dc.subjectFolate conjugatesen_EN
dc.subjectPositron emission tomography (PET)en_EN
dc.subjectFluorescent probesen_EN
dc.subjectDendrimersen_EN
dc.subjectNanoparticlesen_EN
dc.titleHDAC Inhibitors: Innovative Strategies for Their Design and Applications.-
dc.typeArtículo-
dc.identifier.doihttps://doi.org/10.3390/molecules27030715-
dc.centroUniversidad San Pablo-CEU-
Aparece en las colecciones: Facultad de Farmacia




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.